Product
CinnaTropin®
1 clinical trial
1 indication
Indication
Growth Hormone DeficiencyClinical trial
Efficacy and Safety of CinnaGen Recombinant Human Growth Hormone (CinnaTropin®) in Comparison With Novo Nordisk Growth Hormone (Nordilet®) Product in Pre-Pubertal Children With Idiopathic Growth Hormone Deficiency (IGHD)Status: Completed, Estimated PCD: 2017-02-04